Skip to main content

Table 1 Patient data

From: The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma

Tumor id

Outcome

INRG

age at diagnosis

age at follow up

1p-del

MNA

11q-del

17q-gain

10E6

NED

M

<18 m

>60 m

pos

pos

neg

pos

10E7

DOD

M

>18 m

<60 m

neg

neg

neg

pos

10R2

DOD

M

<18 m

<60 m

pos

pos

neg

pos

10R4

NED

MS

<18 m

>60 m

neg

neg

neg

neg

10R8

DOD

L

>18 m

<60 m

neg

neg

pos

neg

11E1

NED

M

>18 m

>60 m

neg

neg

pos

pos

11E8

NED

L

<18 m

>60 m

neg

neg

neg

neg

11R9

DOD

M

>18 m

<60 m

neg

neg

pos

pos

12E5

NED

MS

<18 m

>60 m

neg

neg

neg

neg

12R1

NED

M

<18 m

>60 m

pos

neg

neg

pos

12R6

DOD

M

>18 m

<60 m

pos

pos

neg

neg

12R9

NED

M

>18 m

>60 m

neg

pos

neg

neg

13R0

DOD

M

>18 m

<60 m

neg

pos

pos

pos?

13R1

DOD

L

>18 m

<60 m

neg

pos

pos

pos

15R8

NED

L

<18 m

>60 m

pos

neg

pos

pos

16E2

NED

L

<18 m

>60 m

neg

neg

neg

neg

16E9

DOD

M

>18 m

<60 m

neg

pos

neg

pos?

16R4

NED

L

>18 m

>60 m

neg

pos

neg

pos

17E2

NED

L

>18 m

>60 m

neg

neg

neg

neg

17E4

DOD

M

>18 m

<60 m

neg

pos

pos

pos

18E2

NED

L

>18 m

>60 m

pos

neg

neg

pos

18E4

DOD

M

<18 m

<60 m

neg

pos

pos

pos

18E5

NED

L

>18 m

>60 m

neg

neg

neg

neg

18E7

NED

L

>18 m

>60 m

neg

neg

neg

pos

18E8

NED

L

<18 m

>60 m

neg

neg

neg

neg

19R1

NED

L

>18 m

>60 m

neg

neg

neg

neg

19R6

DOD

L

<18 m

<60 m

neg

pos

pos

pos

20R8

NED

L

>18 m

>60 m

neg

pos

pos

pos

23R2

NED

L

>18 m

>60 m

neg

pos

  

23R4

NED

L

<18 m

>60 m

neg

neg

neg

neg

25R6

DOD

M

>18 m

<60 m

neg

pos

pos

pos

25R7

NED

L

<18 m

>60 m

neg

neg

neg

neg

26R0

NED

M

>18 m

>60 m

pos

neg

pos

pos

26R1

NED

L

<18 m

>60 m

neg

neg

neg

neg

27R7

NED

L

<18 m

>60 m

neg

neg

neg

neg

28R2

NED

 

<18 m

>60 m

neg

pos

pos

pos

30R0

NED

M

>18 m

>60 m

pos

neg

neg

neg

32R2

NED

M

>18 m

>60 m

pos

neg

pos

pos

34R0

DOD

M

>18 m

<60 m

neg

neg

neg

pos

34R5

NED

L

<18 m

<60 m

neg

neg

neg

neg

35R5

NED

L

<18 m

<60 m

neg

neg

neg

neg

35R7

DOD

M

<18 m

<60 m

pos

neg

neg

neg

36R1

DOD

M

>18 m

<60 m

pos

neg

neg

pos

36R2

NED

M

>18 m

<60 m

pos

neg

neg

pos

36R3

DOD

MS

<18 m

<60 m

neg

neg

neg

pos

37R5

NED

L

<18 m

<60 m

neg

neg

neg

neg

37R6

NED

L

<18 m

<60 m

neg

neg

neg

neg

38R6

NED

L

>18 m

<60 m

neg

neg

pos

neg

39R1

NED

M

>18 m

<60 m

neg

pos

pos

pos

3E2

DOD

M

>18 m

<60 m

pos

neg

neg

pos

43R2

DOD

M

<18 m

<60 m

neg

neg

neg

pos

43R3

NED

M

>18 m

<60 m

neg

pos

pos

pos

4E1

DOD

M

>18 m

<60 m

pos

neg

neg

pos

5E1

NED

L

<18 m

>60 m

neg

neg

neg

neg

6E9

DOD

L

>18 m

<60 m

pos

neg

pos

pos

8E4

NED

L

<18 m

>60 m

neg

neg

neg

neg

8E7

NED

L

>18 m

>60 m

neg

neg

neg

neg

9E5

DOD

M

>18 m

<60 m

neg

pos

pos

pos

9R9

DOD

M

>18 m

<60 m

pos

neg

pos

pos

  1. NED, no evidence of disease; DOD, dead of disease; L, localized; M, metastatic; m, months.
  2. 1p-del, 1p-deletion; MNA, MYCN amplification; 11q-del, 11q-deletion; neg, negative; pos, positive.